Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 1

Status

Unknown 5Recruiting 5Active not recruiting 4Not yet recruiting 2Completed 2

Sponsor Class

OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Myeloid 7Lymphoid 5

Conditions

Lymphoma 335Precursor Cell Lymphoblastic Leukemia-Lymphoma 292Lymphoma, Large B-Cell, Diffuse 216Lymphoma, Non-Hodgkin 192Lymphoma, Follicular 172Leukemia, Lymphocytic, Chronic, B-Cell 129Lymphoma, B-Cell 123Hodgkin Disease 112Leukemia 104Recurrence 100Lymphoma, Mantle-Cell 89Burkitt Lymphoma 88Lymphoma, T-Cell, Peripheral 60Lymphoma, Extranodal NK-T-Cell 56Multiple Myeloma 53Leukemia, Myeloid, Acute 53Lymphoma, B-Cell, Marginal Zone 51Lymphoma, T-Cell 41Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 39Neoplasms 39Leukemia, B-Cell 39Lymphoma, T-Cell, Cutaneous 37Lymphoma, Large-Cell, Immunoblastic 31Myelodysplastic Syndromes 30Hematologic Neoplasms 25Mycosis Fungoides 24Lymphoma, Large-Cell, Anaplastic 24Neoplasms, Plasma Cell 23Waldenstrom Macroglobulinemia 22Immunoblastic Lymphadenopathy 22

Interventions

Etoposide 3pegaspargase 2Gemcitabine 2Dexamethasone 2sintilimab 1ruxolitinib 1Vincristine 1Th1-Th2 Balance 1Prednisone 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1EPOCH protocol 1Doxorubicin 1Cyclophosphamide 1Cisplatin 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × Lymphohistiocytosis, Hemophagocytic × Lymphoid × Clear all
NCT05600959 2022-11-01

Sensitivity and Specificity of Cytokines in the Diagnosis of Lymphoma-associated HLH

Beijing Friendship Hospital

Unknown
60 enrolled
LymphoidMyeloid

Disease, Lymphoma, Lymphohistiocytosis, Hemophagocytic

NCT05008666 2021-08-17

Induction Chemotherapy Sequential Sintilimab Combined With Dual Epigenetic Drugs for ENKTL-HLH

Sun Yat-sen University

Phase 2 Unknown
37 enrolled
LymphoidMyeloid

Lymphohistiocytosis, Hemophagocytic, Lymphoma, Extranodal NK-T-Cell

NCT04999878 2021-08-11

RUE-DDGP

Zhengzhou University

Phase 4 Unknown
30 enrolled
LymphoidMyeloid

Lymphohistiocytosis, Hemophagocytic, Lymphoma, Extranodal NK-T-Cell

NCT04405375 2020-05-28

GPED Regimen for Relapsed/Refractory or Advanced ENKTCL

Beijing Tongren Hospital

Phase 2 Unknown
29 enrolled
LymphoidMyeloid

Lymphohistiocytosis, Hemophagocytic, Lymphoma, Extranodal NK-T-Cell

NCT01818908 2019-02-15

Trial of DA-EPOCH Regimen for NHL With HLH

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Unknown
50 enrolled
LymphoidMyeloid

Lymphoma, Non-Hodgkin, Lymphohistiocytosis, Hemophagocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡